title: Effect of a somatostatin analog (SMS 201-995) in perfusion on basal and pentagastrin-stimulated calcitonin levels in medullary thyroid carcinoma.
authors.affiliation: Département d'Endocrinologie, Hôpital Avicenne, Bobigny, Lyon, France.
authors.forename: E
authors.initials: E
authors.lastname: Modigliani
authors.forename: J A
authors.initials: JA
authors.lastname: Chayvialle
authors.forename: R
authors.initials: R
authors.lastname: Cohen
authors.forename: G
authors.initials: G
authors.lastname: Perret
authors.forename: J M
authors.initials: JM
authors.lastname: Guliana
authors.forename: R
authors.initials: R
authors.lastname: Vassy
authors.forename: P
authors.initials: P
authors.lastname: Roger
authors.forename: C
authors.initials: C
authors.lastname: Siame-Mourot
authors.forename: M
authors.initials: M
authors.lastname: Bennet
authors.forename: M
authors.initials: M
authors.lastname: Bentata-Pessayre
mesh_terms: D000328:Adult; D002116:Calcitonin / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000494:pharmacology*; D010418:Pentagastrin / Q000494:pharmacology; D013004:Somatostatin / Q000097:blood; D013964:Thyroid Neoplasms / Q000097:blood*
chemical_list: D013004:Somatostatin; D002116:Calcitonin; D010418:Pentagastrin; D015282:Octreotide